Arcutis to Present at the Guggenheim SMID Cap Biotech Conference

Company Overview - Arcutis Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company focused on immuno-dermatology, addressing urgent needs in immune-mediated dermatological diseases [2] - The company has a growing portfolio that includes three FDA-approved products and a robust pipeline targeting various inflammatory dermatological conditions such as scalp and body psoriasis, atopic dermatitis, and alopecia areata [2] Upcoming Events - Arcutis management will participate in the Guggenheim SMID Cap Biotech Conference on February 5-6, 2025, with a fireside chat scheduled for February 6, 2025, at 1:00 pm ET [1] - The conference webcast will be accessible on the company's website, with a replay available for 180 days post-conference [1]